Head and neck cancer: Buparlisib is an effective second-line treatment.

Head and neck cancer: Buparlisib is an effective second-line treatment.

Nat Rev Clin Oncol. 2017 Feb 14;:

Authors: Sidaway P

PMID: 28195237 [PubMed - as supplied by publisher]

http://ift.tt/2kwMJNE